Metraipolis › archive › dc_4289f5352bee
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42221586
- DOI
- 10.3389/fcimb.2026.1777714
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:33:53.444Z
- SHA-256 of the archived text
fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d- Stable URL of this page
https://metraipolis.com/documento/dc_4289f5352bee
How to cite
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586 — Europe PMC (en), https://europepmc.org/article/MED/42221586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4289f5352bee (Metraipolis archive dc_4289f5352bee, sha256 fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d)
BibTeX
@misc{dc4289f5352bee,
title = {Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42221586},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4289f5352bee; sha256 fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42221586. Agents can read the archived copy with the MCP tool read_document.